Ventilator News and Research RSS Feed - Ventilator News and Research

Reduced RV functional reserve may explain poor SSc-PAH outcomes

Reduced RV functional reserve may explain poor SSc-PAH outcomes

Patients who develop pulmonary arterial hypertension as a consequence of systemic sclerosis have poorer right ventricular functional reserve than those with idiopathic disease, research published in Circulation shows. [More]
Medical applications of world’s smallest differential pressure sensor: an interview with Daniel Träutlein

Medical applications of world’s smallest differential pressure sensor: an interview with Daniel Träutlein

When Sensirion developed the first generation of differential pressure sensors (SDP1108 series), size was not of the essence. Instead Sensirion showed that it could provide, with the thermal flow through technique, a differential pressure sensor which is superior in performance, especially for low differential pressures. [More]
Dishwasher and laundry capsules pose threat to children

Dishwasher and laundry capsules pose threat to children

Parents are being warned of the major health risks of children mistaking potentially harmful dishwasher and laundry capsules for sweets, after figures showed at least one case is happening every day. [More]
Japanese surgeons develop new technique to relieve airway obstruction in children

Japanese surgeons develop new technique to relieve airway obstruction in children

Several pediatric medical conditions, such as congenital heart disease, vascular compression, and congenital softening of the cartilage lining the trachea or bronchi, can compromise the airway and cause breathing difficulty. [More]
Experimental hepatitis C drug slows down development of Zika in mice

Experimental hepatitis C drug slows down development of Zika in mice

Virologists from KU Leuven, Belgium, have shown that an experimental antiviral drug against hepatitis C slows down the development of Zika in mice. The research team was led by Professor Johan Neyts from the Laboratory of Virology and Chemotherapy. [More]
New CMR imaging technique increases accuracy by eliminating patients' need to breathe naturally

New CMR imaging technique increases accuracy by eliminating patients' need to breathe naturally

A new technique for cardiac magnetic resonance (CMR) imaging improves accuracy by removing patients' need to breathe, reveals research presented today at EuroCMR 2016 by Professor Juerg Schwitter, director of the Cardiac MR Centre at the University Hospital Lausanne, Switzerland. [More]
New Canadian study highlights need to consider mental health of caregivers in post-ICU care

New Canadian study highlights need to consider mental health of caregivers in post-ICU care

A new Canadian study focusing on caregiver outcomes of critically ill patients reveals that caregivers of intensive care unit (ICU) survivors, who have received mechanical ventilation for a minimum of seven days, are at a high risk of developing clinical depression persisting up to one year after discharge. [More]
Cerebellar not cerebral atrophy predicts poor anti-NMDAR encephalitis outcome

Cerebellar not cerebral atrophy predicts poor anti-NMDAR encephalitis outcome

Diffuse cerebral atrophy in patients with anti-N-methyl-D-aspartate receptor encephalitis does not necessarily mean irreversible brain damage, whereas progressive cerebellar atrophy may indicate a poor long-term prognosis, researchers report. [More]
Analysis reveals improved survivorship for acute liver failure patients

Analysis reveals improved survivorship for acute liver failure patients

More patients hospitalized with acute liver failure - often the result of acetaminophen overdose - are surviving, including those who receive a liver transplant and those who don't, an analysis led by a UT Southwestern Medical Center researcher showed. [More]
Two established atrial fibrillation ablation techniques show similar effects, safety outcomes

Two established atrial fibrillation ablation techniques show similar effects, safety outcomes

Two established techniques for correcting the root cause of the heart rhythm disorder atrial fibrillation show similar effects and safety outcomes, according to research presented at the American College of Cardiology's 65th Annual Scientific Session. [More]
Cardiac clot-busting drug decreases mortality in hemorrhagic stroke patients

Cardiac clot-busting drug decreases mortality in hemorrhagic stroke patients

Reporting on the results of a phase III international clinical trial, Johns Hopkins Medicine physicians say use of a cardiac clot-busting drug to treat strokes that cause brain bleeding safely decreased the death rate in patients by 10 percent, compared to a control group receiving saline. [More]
Study: Delirium, muscle weakness and other neurological complications of sepsis poorly understood

Study: Delirium, muscle weakness and other neurological complications of sepsis poorly understood

Delirium, muscle weakness and other neurological complications of sepsis often are overlooked and poorly understood, according to a study published in the journal Current Neurology and Neurosciences Reports. [More]
CHLA researchers develop novel model for studying neonatal lung disorder

CHLA researchers develop novel model for studying neonatal lung disorder

Investigators at The Saban Research Institute of Children's Hospital Los Angeles have created a novel model for studying a lung disorder of newborn babies. Their study, published in PLOS ONE on February 10, describes the first model that allows investigators to consider the chronic effects of developmental lung disease. [More]
Covestro to showcase high-performance materials for medical applications at MD&M West 2016

Covestro to showcase high-performance materials for medical applications at MD&M West 2016

With people living longer and leading more-active lives, demands placed on medical equipment have grown. The medical wearable electronics market has evolved to provide patients with a more comfortable experience, while enabling them to be mobile and limit time spent in the hospital for treatment and maintenance. [More]
New breakthrough drug shows promise to fight antibiotic-resistant infections

New breakthrough drug shows promise to fight antibiotic-resistant infections

A New York pharmaceutical company, TGV-Laboratories, has developed a groundbreaking drug that shows promise in treating a wide variety of antibiotic-resistant fungal and bacterial infections. [More]
Bridion injection approved to reverse effects of neuromuscular blocking drugs used during certain types of surgery

Bridion injection approved to reverse effects of neuromuscular blocking drugs used during certain types of surgery

The U.S. Food and Drug Administration today approved Bridion (sugammadex) injection to reverse the effects of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide, which are used during certain types of surgery in adults. [More]
Queen's University Belfast-led study examines potential of new technology that could save lives in ICUs

Queen's University Belfast-led study examines potential of new technology that could save lives in ICUs

A potentially revolutionary new technology - that could saves thousands of lives in Intensive Care Units around the world - is being trialled in a UK study co-led by Queen's University Belfast. [More]
Study: Post hospital syndrome is significant risk factor for patients undergoing elective surgery

Study: Post hospital syndrome is significant risk factor for patients undergoing elective surgery

A condition known as "post hospital syndrome" (PHS) is a significant risk factor for patients who undergo elective outpatient surgery, a Loyola study has found. [More]
CareFusion to display new respiratory solutions at AARC Congress

CareFusion to display new respiratory solutions at AARC Congress

CareFusion, a BD company, will be displaying new respiratory solutions that are designed to put patients first, whether ventilated or breathing on their own, at the American Association for Respiratory Care Congress being held Nov. 7-10 in Tampa, Fla. [More]
Mallinckrodt announces approval of INOmax for cardiovascular surgery in Australia and Japan

Mallinckrodt announces approval of INOmax for cardiovascular surgery in Australia and Japan

Mallinckrodt plc, a leading specialty biopharmaceutical company, today announced that INOmax (nitric oxide) for inhalation has received regulatory approval in Australia and Japan for pulmonary hypertension in conjunction with heart surgery. [More]
Advertisement
Advertisement